Inolimomab is a mouse monoclonal antibody developed as an immunosuppressive drug against graft-versus-host disease. Its target is the alpha chain of the...
2 KB (137 words) - 06:39, 11 August 2023
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
22 KB (1,789 words) - 04:29, 16 July 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
17 KB (1,245 words) - 04:39, 17 August 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
31 KB (2,444 words) - 00:18, 6 August 2024
Tocilizumab LFA-1 Odulimomab IL-2 receptor/CD25 Basiliximab Daclizumab Inolimomab T-lymphocyte (Zolimomab aritox) Unsorted Alemtuzumab Anifrolumab Atorolimumab...
7 KB (299 words) - 13:45, 27 April 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
22 KB (2,581 words) - 20:03, 21 June 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
16 KB (1,451 words) - 18:24, 2 August 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
43 KB (3,662 words) - 19:35, 12 July 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
14 KB (1,037 words) - 04:45, 6 July 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
24 KB (2,070 words) - 07:13, 15 March 2024
colitis Intetumumab mab human CD51 solid tumors (prostate cancer, melanoma) Inolimomab mab mouse CD25 (α chain of IL-2 receptor) graft versus host disease Inotuzumab...
136 KB (4,020 words) - 07:14, 15 August 2024
Nivolumab/relatlimab Mouse Afelimomab Elsilimomab Faralimomab Gavilimomab Inolimomab Maslimomab Nerelimomab Odulimomab Telimomab aritox Vepalimomab Zolimomab...
38 KB (4,304 words) - 10:14, 21 July 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
9 KB (587 words) - 20:04, 20 December 2023
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
14 KB (1,147 words) - 07:33, 11 August 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
22 KB (2,510 words) - 04:11, 12 August 2024
Innohep Innopran XL Innovar Inocor inocoterone (INN) inogatran (INN) inolimomab (INN) inolitazone (INN) inotuzumab ozogamicin (INN) Inomax (Ikaria) inosine...
9 KB (483 words) - 20:19, 27 May 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
20 KB (2,192 words) - 23:02, 27 November 2023
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
5 KB (272 words) - 03:23, 14 August 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
12 KB (1,289 words) - 19:20, 4 December 2023
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
49 KB (6,005 words) - 16:30, 10 June 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
43 KB (5,000 words) - 13:28, 1 July 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
35 KB (3,989 words) - 13:32, 13 July 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
40 KB (4,858 words) - 14:50, 21 July 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
22 KB (2,786 words) - 02:02, 19 August 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
19 KB (2,293 words) - 11:05, 8 March 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
26 KB (3,305 words) - 17:31, 8 August 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
12 KB (1,315 words) - 19:57, 6 May 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
15 KB (1,264 words) - 06:00, 18 July 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
11 KB (813 words) - 11:58, 6 August 2024
Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim Milodistim Muplestim...
13 KB (1,523 words) - 19:27, 26 June 2024